Results 61 to 70 of about 463 (98)

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors. [PDF]

open access: yesInt J Mol Sci, 2023
Geiger N   +10 more
europepmc   +1 more source

A lysine-based 2:1-[α/aza]-pseudopeptide series used as additives in polymeric membranes for CO2 capture: synthesis, structural studies, and application. [PDF]

open access: yesRSC Adv, 2023
Ibrahim MIA   +9 more
europepmc   +1 more source

AApeptides as a New Class of Peptidomimetics to Regulate Protein-Protein Interactions [PDF]

open access: yes, 2012
Haifan Wu   +6 more
core   +1 more source

Peptide-Based Drug Development. [PDF]

open access: yesBiomedicines, 2022
Lubell WD.
europepmc   +1 more source

Editorial: Design of Macrocyclic Compounds for Biomedical Applications. [PDF]

open access: yesFront Chem, 2021
Padnya PL, Wu X, Erxleben A, Braga SS.
europepmc   +1 more source

Access to <i>N</i>‑Fluorinated Azapeptides and Azapeptoids as Peptidomimetic Scaffolds. [PDF]

open access: yesACS Org Inorg Au
Kyrko D   +4 more
europepmc   +1 more source

An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease

open access: yes, 2023
Khatua K   +18 more
europepmc   +1 more source

Smart therapies against global pandemics: A potential of short peptides. [PDF]

open access: yesFront Pharmacol, 2022
Apostolopoulos V   +4 more
europepmc   +1 more source

Metallo-azapeptides: Controlled Metal Chelation to Peptide Backbone Nitrogen. [PDF]

open access: yesJ Am Chem Soc
Bowles MO   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy